Oruka Therapeutics (NasdaqGM:ORKA) 2025 Conference November 11, 2025 04:40 PM ET Speaker0Q&A.Speaker1Sure. Thanks, Alex. Thanks for having us, and thanks everybody for joining. Oruka Therapeutics is focused on advancing the standard of care in psoriatic disease. Our pipeline is anchored around two co-lead assets, ORCA-001 and ORCA-002. They are both extended half-life monoclonal antibodies, aiming to offer improved product profiles in plaque psoriasis, psoriatic arthritis, and some associated conditions. Th ...